Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis
Shuo Zhang, Weijian Liu, Binwu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma
Philip Bischoff, Alexandra Trinks, Benedikt Obermayer, et al.
Oncogene (2021) Vol. 40, Iss. 50, pp. 6748-6758
Open Access | Times Cited: 138
Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
Hao Chi, Xixi Xie, Yingjie Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 91
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 88
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Elizabeth Hawkins, Reena R. D’Souza, Astero Klampatsa
Biologics (2021) Vol. Volume 15, pp. 95-105
Open Access | Times Cited: 82
Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
Jiao Wang, Sandra Toregrosa-Allen, Bennett D. Elzey, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 45
Open Access | Times Cited: 59
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors
Matteo Gallazzi, Denisa Baci, Lorenzo Mortara, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 58
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Cristina Capuano, Chiara Pighi, Simone Battella, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2500-2500
Open Access | Times Cited: 51
Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors
Emre Balta, Guido H. Wabnitz, Yvonne Samstag
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5736-5736
Open Access | Times Cited: 48
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Teresa Franchi-Mendes, Rodrigo Eduardo, Giacomo Domenici, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4610-4610
Open Access | Times Cited: 43
Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA)
Nic G. Reitsam, Bruno Märkl, Sebastian Dintner, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 994-994
Open Access | Times Cited: 20
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis
Lauren M. Perry, Sylvia M. Cruz, Kara T. Kleber, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e004285-e004285
Open Access | Times Cited: 18
Combined use of NK cells and radiotherapy in the treatment of solid tumors
Zheng Wang, Sunkai Ling, Yuandong Cao, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Natural killer cell engagers for cancer immunotherapy
Shahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi
Frontiers in Oncology (2025) Vol. 14
Open Access
Spatial Organization and Prognostic Significance of NK and NKT-like Cells via Multimarker Analysis of the Colorectal Cancer Microenvironment
Juha P. Väyrynen, Koichiro Haruki, Mai Chan Lau, et al.
Cancer Immunology Research (2021) Vol. 10, Iss. 2, pp. 215-227
Open Access | Times Cited: 37
Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
Hansol Lee, Inês Pires da Silva, Umaimainthan Palendira, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1363-1363
Open Access | Times Cited: 35
Natural Killer Cells in the Malignant Niche of Multiple Myeloma
Ondrej Venglár, Julio Rodriguez Bagó, Benjamin Motais, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
Next Generation Natural Killer Cells for Cancer Immunotherapy
Fiorella Rossi, Nathaniel Fredericks, Andrew Snowden, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
CAR NK Cells: The Future Is Now
Martin Raftery, Alexander Sebastian Franzén, Gabriele Pecher
Annual Review of Cancer Biology (2023) Vol. 7, Iss. 1, pp. 229-246
Open Access | Times Cited: 14
Advances in natural killer cell therapies for breast cancer
Seyedeh Zahra Fotook Kiaei, Alireza Nouralishahi, Mohammad Ghasemirad, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 8, pp. 705-726
Open Access | Times Cited: 14
Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma
Ana Căruntu, Liliana Moraru, Mihai Lupu, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2268-2268
Open Access | Times Cited: 30
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
Alessandra Zecca, Valeria Barili, Danila Rizzo, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 614-614
Open Access | Times Cited: 29
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
Guang‐Yu Lian, Thomas Shiu‐Kwong Mak, Xueqing Yu, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 164-164
Open Access | Times Cited: 29
Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
Éilis Russell, Melissa J. Conroy, Martin P. Barr
Cells (2022) Vol. 11, Iss. 4, pp. 605-605
Open Access | Times Cited: 21
Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells
Emily Cluff, Carina Magdaleno, Emyly Fernandez, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 8, pp. 1989-2005
Open Access | Times Cited: 20
Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients
Chenglong Li, Fangkun Liu, Lun‐Quan Sun, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top